bluebird bio (BLUE) Extend Rally as Analysts Reflect Positively on Zynteglo Approval

Like
1
Favorite

bluebird bio (BLUE) Extend Rally as Analysts Reflect Positively on Zynteglo Approval

StreetInsider2022-08-18

Shares of Bluebird Bio (NASDAQ: BLUE) are up over 10% today after the United States Food and Drug Administration (FDA) ...(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

Gzgz
·2022-08-18
Pump n dump
Reply
Like
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2260331548?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-08-18 21:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2260331548","market":"us","top_or_hot":-1,"title":"bluebird bio (BLUE) Extend Rally as Analysts Reflect Positively on Zynteglo Approval","media":"StreetInsider","content":"<div>\n<p>Shares of Bluebird Bio (NASDAQ: BLUE) are up over 10% today after the United States Food and Drug Administration (FDA) ...(Premium-only article. Please sign in or upgrade to SI Premium to view.)</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=20483926\">Source Link</a>\n\n</div>\n","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>bluebird bio (BLUE) Extend Rally as Analysts Reflect Positively on Zynteglo Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nbluebird bio (BLUE) Extend Rally as Analysts Reflect Positively on Zynteglo Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-18 21:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=20483926><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Bluebird Bio (NASDAQ: BLUE) are up over 10% today after the United States Food and Drug Administration (FDA) ...(Premium-only article. Please sign in or upgrade to SI Premium to view.)</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=20483926\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BLUE","symbol_name":"bluebird bio Inc.","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=20483926","article_id":"2260331548","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2260331548","pubTimestamp":1660828500,"columns":[],"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"Shares of Bluebird Bio (NASDAQ: BLUE) are up over 10% today after the United States Food and Drug Ad","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BLUE":"bluebird bio Inc.","BK4556":"基因编辑","BK4578":"CAR-T","BK4139":"生物科技"},"translate_title":"蓝鸟生物公司(BLUE)股价上涨，分析师对Zynteglo批准持积极态度","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLUE":1},"content_text":"Shares of Bluebird Bio (NASDAQ: BLUE) are up over 10% today after the United States Food and Drug Administration (FDA) ...(Premium-only article. Please sign in or upgrade to SI Premium to view.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":9991643040,"gmtCreate":1660832079982,"gmtModify":1676536407253,"author":{"id":"3567393794802705","authorId":"3567393794802705","name":"Gzgz","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":8,"crmLevelSwitch":0,"idStr":"3567393794802705","authorIdStr":"3567393794802705"},"htmlText":"Pump n dump","listText":"Pump n dump","text":"Pump n dump","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9991643040","repostId":2260331548,"repostType":2,"repost":{"id":"2260331548","kind":"highlight","pubTimestamp":1660828500,"share":"https://ttm.financial/m/news/2260331548?lang=&edition=fundamental","pubTime":"2022-08-18 21:15","market":"us","language":"en","title":"bluebird bio (BLUE) Extend Rally as Analysts Reflect Positively on Zynteglo Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2260331548","media":"StreetInsider","summary":"Shares of Bluebird Bio (NASDAQ: BLUE) are up over 10% today after the United States Food and Drug Ad","content":"<html><body><div>\n<div>\n<div>\n<img src=\"https://www.streetinsider.com/images/summaries/1241/resize_BLUEBIRDBIO.jpg\"/>\n</div>\n</div>\nShares of Bluebird Bio (NASDAQ: BLUE) are up over 10% today after the United States Food and Drug Administration (FDA) ...<br/><br/>(Premium-only article. Please sign in or upgrade to SI Premium to view.)<div><div><div></div></div></div> </div></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>bluebird bio (BLUE) Extend Rally as Analysts Reflect Positively on Zynteglo Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nbluebird bio (BLUE) Extend Rally as Analysts Reflect Positively on Zynteglo Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-18 21:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=20483926><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Bluebird Bio (NASDAQ: BLUE) are up over 10% today after the United States Food and Drug Administration (FDA) ...(Premium-only article. Please sign in or upgrade to SI Premium to view.)</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=20483926\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4139":"生物科技","BLUE":"bluebird bio Inc.","BK4556":"基因编辑","BK4578":"CAR-T"},"source_url":"https://www.streetinsider.com/dr/news.php?id=20483926","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2260331548","content_text":"Shares of Bluebird Bio (NASDAQ: BLUE) are up over 10% today after the United States Food and Drug Administration (FDA) ...(Premium-only article. Please sign in or upgrade to SI Premium to view.)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}